1 Professor of Neurological-Surgery, Neuroscience Research Center, Department of Neurosurgery, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Student Member of Road Accidents Research Committee and Knowledge Management Unit, Tabriz University of Medical Sciences (Bio-Medicine), Tabriz, IR Iran
3 Road Traffic Injury Research Center, Department of Statistics and Epidemiology, Tabriz University of Medical Sciences, Tabriz, IR Iran
To Cite:
Meshkini
A, Meshkini
M, Sadeghi-Bazargani
H. Erythropoietin for Traumatic Brain Injury: A Systematic Review and Meta-Analysis,
Trauma Mon.
2017
; 22(5):e37191.
doi: 10.5812/traumamon.37191.
1.
Bennett MH, Trytko B, Jonker B. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury. Cochrane Database Syst Rev. 2012; 12[DOI][PubMed]
2.
Schierhout G, Roberts I. Hyperventilation therapy for acute traumatic brain injury. Cochrane Database Syst Rev. 2000; (2)[DOI][PubMed]
3.
Thompson K, Pohlmann-Eden B, Campbell LA, Abel H. Pharmacological treatments for preventing epilepsy following traumatic head injury. Cochrane Database Syst Rev. 2015; (8)[DOI][PubMed]
4.
Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2005; (1)[DOI][PubMed]
5.
Ma J, Huang S, Qin S, You C. Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev. 2012; 10[DOI][PubMed]
6.
Sahuquillo J, Arikan F. Decompressive craniectomy for the treatment of refractory high intracranial pressure in traumatic brain injury. Cochrane Database Syst Rev. 2006; (1)[DOI][PubMed]
7. Traumatic brain injury. 2002;
8.
Abrishamkar S, Safavi M, Honarmand A. Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Sale in patient with diffuse axonal injury. J Res Med Sci. 2012; 17(1): 51-6[PubMed]
9.
Nichol A,
French C,
Little L,
Haddad S,
Presneill J,
Arabi Y,
et al.
Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet. 2015; 386(10012): 2499-506[DOI][PubMed]
10.
Presneill J,
Little L,
Nichol A,
French C,
Cooper DJ,
Haddad S,
et al.
Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury. Trials. 2014; 15: 501[DOI][PubMed]
11.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. 2011;
13.
Mammis A, McIntosh TK, Maniker AH. Erythropoietin as a neuroprotective agent in traumatic brain injury Review. Surg Neurol. 2009; 71(5): 527-31[DOI][PubMed]
14.
Talving P,
Lustenberger T,
Kobayashi L,
Inaba K,
Barmparas G,
Schnuriger B,
et al.
Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study. Ann Surg. 2010; 251(1): 1-4[DOI][PubMed]
15.
Aloizos S, Evodia E, Gourgiotis S, Isaia EC, Seretis C, Baltopoulos GJ. Neuroprotective Effects of Erythropoietin in Patients with Severe Closed Brain Injury. Turk Neurosurg. 2015; 25(4): 552-8[DOI][PubMed]
16.
Leucht S, Helfer B, Gartlehner G, Davis JM. How effective are common medications: a perspective based on meta-analyses of major drugs. BMC Med. 2015; 13: 253[DOI][PubMed]
17.
Zafonte RD,
Bagiella E,
Ansel BM,
Novack TA,
Friedewald WT,
Hesdorffer DC,
et al.
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. 2012; 308(19): 1993-2000[DOI][PubMed]
18.
Skolnick BE,
Maas AI,
Narayan RK,
van der Hoop RG,
MacAllister T,
Ward JD,
et al.
A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014; 371(26): 2467-76[DOI][PubMed]
19.
Wright DW,
Yeatts SD,
Silbergleit R,
Palesch YY,
Hertzberg VS,
Frankel M,
et al.
Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014; 371(26): 2457-66[DOI][PubMed]
20.
Menon DK. Unique challenges in clinical trials in traumatic brain injury. Crit Care Med. 2009; 37(1 Suppl): 129-35[DOI][PubMed]
Readers' Comments